Changes in gene expression in responders and nonresponders to a low-intensity walking intervention

Diabetes Care

Volumn 38, Issue 6, 2015, Pages 1154-1160

  Osler, Megan E ^a   Fritz, Tomas ^a   Caidahl, Kenneth ^a   Krook, Anna ^a   Zierath, Juleen R ^a   Wallberg Henriksson, Harriet ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MESSENGER RNA; GENETIC MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXERCISE INTENSITY; FEMALE; GENE EXPRESSION; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; MALE; METABOLIC REGULATION; MIDDLE AGED; MUSCLE BIOPSY; OBESITY; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT RESPONSE; VASTUS LATERALIS MUSCLE; WAIST CIRCUMFERENCE; WALKING; WORK CAPACITY; GENETIC MARKER; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; KINESIOTHERAPY; METABOLISM; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERWEIGHT; PHYSIOLOGY; PROCEDURES; SKELETAL MUSCLE; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EXERCISE THERAPY; FEMALE; GENE EXPRESSION; GENETIC MARKERS; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; OBESITY; OVERWEIGHT; RNA, MESSENGER; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WALKING;

EID: 84937434706     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-2606     Document Type: Article

References (40)

1. Zierath JR, Wallberg-Henriksson H. Exercise training in obese diabetic patients. Special considerations. Sports Med 1992;14:171-189.
2. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
3. Tuomilehto J, Lindstrom J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343- 1350.
4. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991;34:891-898.
5. Yoon U, Kwok LL, Magkidis A. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucosetolerance: a systematic review of randomized controlled trials. Metabolism 2013;62:303-314.
6. Colberg SR, Sigal RJ, Fernhall B, et al.; American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 2010;33:2692-2696.
7. Balducci S, Sacchetti M, Haxhi J, et al. Physical exercise as therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev 2014;30(Suppl. 1):13-23.
8. Garber CE, Blissmer B, Deschenes MR, et al.; American College of Sports Medicine. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011;43:1334-1359.
9. Mann S, Beedie C, Balducci S, et al. Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence. Diabetes Metab Res Rev 2014;30: 257-268.
10. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK; American College of Sports Medicine. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009;41:459-471.
11. Garćia-Ṕerez LE, Alvarez M, Dilla T, Gil- Guillen V, Orozco-Beltran D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 2013;4:175-194.
12. Bouchard C, An P, Rice T, et al. Familial aggregation of VO(2max) response to exercise training: results from the HERITAGE Family Study. J Appl Physiol (1985) 1999;87:1003-1008.
13. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc 2001;33:S446-S451 discussion S452-S453.
14. Abate M, Schiavone C, Salini V, Andia I. Management of limited joint mobility in diabetic patients. Diabetes Metab Syndr Obes 2013;6:197-207.
15. Barres R, Osler ME, Yan J, et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 2009;10:189-198.
16. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51: 2944-2950.
17. Leenders M, Verdijk LB, van der Hoeven L, et al. Patients with type 2 diabetes showa greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 2013;14:585-592.
18. Johnson ML, Robinson MM, Nair KS. Skeletal muscle aging and the mitochondrion. Trends Endocrinol Metab 2013;24:247-256.
19. Keller P, Vollaard NB, Gustafsson T, et al. A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype. J Appl Physiol (1985) 2011;110:46-59.
20. Phillips BE, Williams JP, Gustafsson T, et al. Molecular networks of human muscle adaptation to exercise and age. PLoS Genet 2013;9: e1003389.
21. Fritz T, Caidahl K, Krook A, et al. Effects of Nordic walking on cardiovascular risk factors in overweight individuals with type 2 diabetes, impaired or normal glucose tolerance. Diabetes Metab Res Rev 2013;29:25-32.
22. Fritz T, Caidahl K, Osler M, Ostenson CG, Zierath JR, Wandell P. Effects of Nordic walking on health-related quality of life in overweight individuals with type 2 diabetes mellitus, impaired or normal glucose tolerance. Diabet Med 2011;28:1362-1372.
23. Rowlands DS, Page RA, Sukala WR, et al. Multi-omic integrated networks connect DNA methylation and miRNA with skeletal muscle plasticity to chronic exercise in type 2 diabetic obesity. Physiol Genomics 2014;46:747-765.
24. Schmutz S, Dapp C, Wittwer M, Vogt M, Hoppeler H, Fluck M. Endurance training modulates the muscular transcriptome response to acute exercise. Pflugers Arch 2006;451:678-687.
25. Liu D, Sartor MA, Nader GA, et al. Skeletal muscle gene expression in response to resistance exercise: sex specific regulation. BMC Genomics 2010;11:659.
26. Gordon PM, Liu D, Sartor MA, et al. Resistance exercise training influences skeletal muscle immune activation: a microarray analysis. J Appl Physiol (1985) 2012;112:443-453.
27. Raue U, Trappe TA, Estrem ST, et al. Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults. J Appl Physiol (1985) 2012;112:1625-1636.
28. Egan B, O'Connor PL, Zierath JR, O'Gorman DJ. Time course analysis reveals gene-specific transcript and protein kinetics of adaptation to short-term aerobic exercise training in human skeletal muscle. PLoS One 2013;8:e74098.
29. Huffman KM, Koves TR, Hubal MJ, et al. Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness. Diabetologia 2014;57:2282-2295.
30. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001;286:1218-1227.
31. Yates T, Davies M, Gorely T, Bull F, Khunti K. Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care 2009;32: 1404-1410.
32. Venojarvi M, Puhke R, Hamalainen H, et al. Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a longterm exercise and dietary intervention. Diabetes Obes Metab 2005;7:745-754.
33. Gram B, Christensen R, Christiansen C, Gram J. Effects of nordic walking and exercise in type 2 diabetes mellitus: a randomized controlled trial. Clin J Sport Med 2010;20:355-361.
34. Short KR, Bigelow ML, Kahl J, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A 2005; 102:5618-5623.
35. Schrauwen P, Hesselink MK. Oxidative capacity, lipotoxicity, andmitochondrial damage in type 2 diabetes. Diabetes 2004;53:1412-1417.
36. Menshikova EV, Ritov VB, Fairfull L, Ferrell RE, Kelley DE, Goodpaster BH. Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci 2006;61:534-540.
37. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34: 267-273.
38. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003;100:8466-8471.
39. Malin SK, Viskochil R, Oliver C, Braun B. Mild fasting hyperglycemia shifts fuel reliance toward fat during exercise in adults with impaired glucose tolerance. J Appl Physiol (1985) 2013; 115:78-83.
40. Praet SF, van Rooij ES, Wijtvliet A, et al. Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2008;51:736-746.